Trial Profile
The impact of Rimonabant in overweight women with prior gestational diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Rimonabant (Primary)
- Indications Cardiovascular disorders; Dyslipidaemias; Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms RIGD
- 26 Jul 2011 New trial record